Menu
Jonathan Tobin

About Jonathan

Jonathan joined Imperial Innovations in 2011 and specialises in therapeutics and diagnostics investments. He is a board director with diagnostics companies Abingdon Health and Molecular Vision, and a board observer with Cell Medica. Prior to joining Imperial Innovations he worked at MRC Technology, sourcing and evaluating new opportunities for small molecule and antibody drug discovery worldwide. He has a PhD in molecular medicine from UCL, and undertook post-doctoral research at the Cancer Research UK LRI. Jonathan has a First Class degree in Biology from Oxford University and an MBA with Distinction from Imperial College.

Contact

Email jonathan.tobin@imperialinnovations.co.uk

Companies

Therapeutics
Investment amount
£4.8m
Investment share
30.0%
Source
Imperial College London
Investment stage
post-Series A

Developing cell based products for immune reconstitution and ...

Find out more
Therapeutics
Investment amount
£7.5m
Investment share
29.9%
Source
University of Oxford
Investment stage
post-Series A

Innovative therapeutics for serious diseases with a particular ...

Find out more
Medtech
Investment amount
£4.8m
Investment share
36.4%
Source
Imperial College London

Developer and distributer of state-of-the-art diagnostic tools and ...

Find out more